Predict your next investment

Lumibird company logo
Corporation
ELECTRONICS | Technical & Scientific Instrumentation
lumibird.com

See what CB Insights has to offer

Founded Year

2018

Stage

Loan | Alive

Total Raised

$206.04M

Last Raised

$120.84M | 10 mos ago

Revenue

$0000 

About Lumibird

Lumibird was formed by the merger of Keopsys and Quantel Group. The Laser division, incorporating Keopsys, Quantel and SensUp, offers lasers for industrial, defense, scientific and medical applications. Its products are based on 3 key technologies: fiber lasers, solid state lasers and laser diodes. The Quantel Medical division, which mainly offers diagnostic and treatment equipment for ophthalmology based on lasers and ultrasonic sensors.

Lumibird Headquarter Location

2 rue Paul Sabatier

Lannion, 22300,

France

+33 (0)2 96 05 08 00

Latest Lumibird News

Profits up at Lumibird despite lidar slip

Sep 22, 2021

22 Sep 2021 The Paris-listed laser firm Lumibird has reported a sharp increase in profitability, thanks to a combination of markets recovering from the Covid-19 pandemic and the successful integration of 2020 acquisition Ellex within its medical division. The company’s stock price rose in value by around 7 per cent after CEO Marc Le Flohic and colleagues revealed a net income of €5.1 million in the first half of 2021. That compared with a net loss of €1.9 million in the equivalent period of 2020, which included widespread shutdowns as the world reacted to the initial impact of the pandemic. Partly as a result of the addition of Ellex, total company sales jumped by 65 per cent, to €74.5 million, with earnings before interest, tax, depreciation and amortization (EBITDA) near-doubling to €14.3 million. Lidar sourcing delays Lumibird’s photonics division accounted for €34.7 million of that total, up 16 per cent on last year as sales to industrial and scientific markets rose nearly 40 per cent, to €17.1 million. Sales into defense and space applications also showed a strong increase, with the overall division able to off-set a marked contraction in sales of lidar products and post an EBITDA figure of €6.7 million. Lumibird said that its previously fast-growing lidar business had been hit by sourcing delays. Acquired for €62 million in mid-2020, the Australia-based laser and ultrasound equipment firm Ellex helped push Lumibird’s medical division sales to €40.7 million - more than double the €15.8 million figure posted for the first half of 2020. That translated to an EBITDA of €7.6 million for the medical division, up from €2 million a year ago. Expansion plan In an investor presentation accompanying the latest results, Lumibird pointed to successful cross-selling, a boom in orders for ultrasound equipment from the US, and a sharp increase in sales of Quantel-branded lasers for glaucoma treatment in Europe as some of the key reasons for the strong performance. An increase in research and development capacity is also in progress, with a new €7 million, 6000 m2 research and production site just completed. With around €80 million in cash on the firm’s latest balance sheet, Lumibird’s executive team is confident of expanding the business rapidly - reaffirming the target of doubling sales revenues between 2020 and 2023. That would imply annual sales approaching €300 million two years from now, a target that should be helped by the pending acquisition of Saab’s laser rangefinder business , and the 37 per cent stake in Orleans-based lasers and optronics firm CILAS that was acquired by Lumibird in July . • In late trading on the Paris stock market September 22, Lumibird's stock price stood at just over €18 - equivalent to a market captitalization of around €400 million.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Lumibird

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lumibird is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,424 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

Lumibird Patents

Lumibird has filed 1 patent.

The 3 most popular patent topics include:

  • Association football record progressions
  • Optical telescopes
  • Space observatories
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/14/2018

Association football record progressions, Space observatories, Optical telescopes, Vision, Telescopes

Application

Application Date

5/14/2018

Grant Date

Title

Related Topics

Association football record progressions, Space observatories, Optical telescopes, Vision, Telescopes

Status

Application

Lumibird Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Lumibird Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.